Article (Scientific journals)
Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase.
Hebert, Solène; Clavel, Pierre; Maier, Benjamin et al.
2020In Journal of Stroke and Cerebrovascular Diseases, 29 (10), p. 105052
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-S1052305720304705-mainext.pdf
Author postprint (466.94 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antithrombotic; Endovascular treatment; Heparin; Mechanical thrombectomy; Stroke; Anticoagulants; Fibrinolytic Agents; Tissue Plasminogen Activator; Aged; Aged, 80 and over; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Brain Ischemia/diagnosis; Brain Ischemia/therapy; Female; Fibrinolytic Agents/adverse effects; France; Heparin/administration & dosage; Heparin/adverse effects; Humans; Male; Middle Aged; Registries; Retrospective Studies; Risk Factors; Stroke/diagnosis; Stroke/therapy; Thrombolytic Therapy/adverse effects; Time Factors; Tissue Plasminogen Activator/adverse effects; Treatment Outcome; Contraindications, Drug; Thrombectomy/adverse effects; Brain Ischemia; Thrombectomy; Thrombolytic Therapy; Surgery; Rehabilitation; Neurology (clinical); Cardiology and Cardiovascular Medicine
Abstract :
[en] [en] BACKROUND AND PURPOSE: Role of peri-procedural heparin as an adjuvant treatment during mechanical thrombectomy (MT) for patients contra-indicated for alteplase remains a source of debate. METHODS: We included patients from the multicenter French register ETIS that underwent MT without administration of alteplase, and compared patients who received heparin during MT with patients who did not. Heparin impact on outcome were analyzed regarding final TICI score, NIHSS at day one, modified rankin scale (mRS) and intracranial hemorrhagic transformation on imaging at day one. RESULTS: Over 1031 patients, 751 were included between January 2015 and June 2018 in 6 different centers, and 223 (26.69%) received heparin. Heparin administration was associated with a significant deleterious effect on NIHSS at 24h [adjusted OR = 1.2; p = 0.02], mRS at 3 months [adjusted OR 1.58; p = 0.03], and on complete reperfusion [TICI 3 adjusted OR 0.68; p = 0.02]. Heparin administration was associated with a significant reduction of hemorrhagic transformation [adjusted OR 0.48; p = 0.00005]. CONCLUSIONS: Heparin administration during MT seems deleterious for reperfusion and functional outcome. Randomized trials are needed to identify the role of antithrombotic treatments, such as heparin, in the setting of acute ischemic stroke management.
Disciplines :
Neurology
Author, co-author :
Hebert, Solène;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France. Electronic address: shebert@for.paris
Clavel, Pierre;  Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Maier, Benjamin;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Mizutani, Katsuhiro ;  Neurovascular Unit, Foch Hospital, Suresnes, France
Delvoye, François  ;  Université de Liège - ULiège > Département des sciences cliniques ; Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Lapergue, Bertrand;  Neurovascular Unit, Foch Hospital, Suresnes, France
Maacha, Malek Ben;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Fahed, Robert;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France, Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France, Université Paris Denis Diderot, Sorbonne Paris Cite, France
Escalard, Simon ;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Desilles, Jean-Philippe;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France, Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France, Université Paris Denis Diderot, Sorbonne Paris Cite, France
Redjem, Hocine;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Ciccio, Gabriele;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Smajda, Stanislas;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France
Blanc, Raphael;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France, Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France, Université Paris Denis Diderot, Sorbonne Paris Cite, France
Piotin, Michel;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France, Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France, Université Paris Denis Diderot, Sorbonne Paris Cite, France
Mazighi, Mikael;  Interventional Neuroradiology Unit, Fondation Rothschild Hospital, Paris, France, Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France, Université Paris Denis Diderot, Sorbonne Paris Cite, France
More authors (6 more) Less
Language :
English
Title :
Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase.
Publication date :
October 2020
Journal title :
Journal of Stroke and Cerebrovascular Diseases
ISSN :
1052-3057
eISSN :
1532-8511
Publisher :
W.B. Saunders, United States
Volume :
29
Issue :
10
Pages :
105052
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 November 2024

Statistics


Number of views
6 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
9
Scopus citations®
without self-citations
7
OpenCitations
 
6
OpenAlex citations
 
9

Bibliography


Similar publications



Contact ORBi